@xtaldave I know, that's exactly my same position: developing a methodology or use that do develop drugs to sell to some pharma.
In truth, even without the IP we are already talking with investors to get some money to develop it, because with public money we're not even able to do that...
I mean, currently for us even synthesizing compounds is too expensive.